ViewRay , Inc. engages in the design, manufacture and market magnetic resonance imaging (MRI) system. It develops MRIdian to address the key limitations of existing external-beam radiation therapy technologies, and employs MRI-based technology to provide real-time imaging that clearly defines the targeted tumor from the surrounding soft tissue, and other critical organs, both before and during radiation treatment delivery. The company was founded by Dinara Akzhigitova on September 6, 2013 and is headquartered in Oakwood Village, OH.
P/E Current -4.03
P/E Ratio (with extraordinary items) -3.37
SHORT INTEREST 22.51M 07/31/19
Average Recommendation: BUY
Average Target Price: 6.80
Official InvestorsHub (IHUB) Profile for TopMarketGainers.com. Since 2009, we are the #1 Source For #FREE Winning #NASDAQ & #NYSE-Listed Alerts!
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.